Our Team

With decades of experience and a world-renowned network of leaders in clinical drug development and clinical research in psychiatry, our team is leveraging the potential of precision neuropsychiatry to change the way we treat sleep, anxiety and addiction disorders.

Team
davor

Davor Kosanic, PhD

Chief Executive Officer & Co-founder

milan

Milan Scheidegger, MD PhD

Chief Medical Officer & Co-founder

mario

Dario Dornbierer, PhD

Chief Scientific Officer & Co-founder

robert_pic

Robin von Rotz, MS

Chief Clinical Officer & Co-founder

daniel

Daniel Claussen, MBA

Chief Business Officer & Co-founder

emma_pic

Emma Chaffin, PhD

Interim Chief Operating Officer

Otsuka, Jazz & other CNS

mike_e

Mike Emanuel, PhD

Clinops Strategy

J&J, Compass, Gilgamesh

corinne

Corine de Boer, MD PhD

Clinical Trial Strategy

MAPS PBC, Dynavax, Novartis

robert

Robert Hett, PhD

CMC & Quality

Carbogen, RPD

manfred

Manfred Schneider, PhD

Toxicology & Preclinical

MerckSereno, Addex, AUC

fiona

Fiona Cilli, Pharm D

Clinical Operations

Sanofi, Zoersel

nick

Nicholas Draeger, PhD

BD & Strategy

Roche, NHS, Innosuisse

ruth

Ruth Stevens, PhD

Regulatory Consultant

Founder, Camargo
Premier Consulting

claire

Claire Gillis, PhD

Market Access Advisor

CEO, VLMYR Health. WPP

micahel_k

Michael Kometer, PhD

Board Chairman & Co-founder

Neuronomics

gloria_pic

Victoria Hale, PhD

Board of Directors

FDA, Medicines 360,
MAPS Board Chair

david_langer

David Langer

Board Member

Founding Partner,
Lionheart Ventures

Scientific Advisors
eus

Eus van Sommeren, PhD

Stress-induced Insomnia

Head of the Department Sleep & Cognition
University of Amsterdam

hape

Hans-Peter Landolt, PhD

Sleep Pharmacology & Toxicology

University of Zurich

marcus

Marcus Herdener, MD PhD

Cocaine use disorder & addictions

Head of Center for Addictive Disorders
Psychiatric University Clinic, Zurich

erich

Erich Seifritz, MD PhD

Psychiatry & GAD

Director, Psychiatric University Clinic, Zurich

micahel_ashton

Michael Ashton

Pharmacokinetics & Drug Metabolism

Department of Pharmacology,
Institute of Neuroscience and Physiology,
University of Gothenburg

peter

Peter Gasser, MD

Clinical Advisor

Psychedelic Therapy
President, SAPT

With decades of experience and a world-renowned network of leaders in clinical drug development and clinical research in psychiatry, our team is leveraging the potential of precision neuropsychiatry to change the way we treat sleep, anxiety and addiction disorders.

Team
davor

Davor Kosanic, PhD

Chief Executive Officer & Co-founder

milan

Milan Scheidegger, MD PhD

Chief Medical Officer & Co-founder

mario

Dario Dornbierer, PhD

Chief Scientific Officer & Co-founder

robert_pic

Robin von Rotz, MS

Chief Clinical Officer & Co-founder

daniel

Daniel Claussen, MBA

Chief Business Officer & Co-founder

emma_pic

Emma Chaffin, PhD

Interim Chief Operating Officer

Otsuka, Jazz & other CNS

mike_e

Mike Emanuel, PhD

Clinops Strategy

J&J, Compass, Gilgamesh

corinne

Corine de Boer, MD PhD

Clinical Trial Strategy

MAPS PBC, Dynavax, Novartis

antonella

Antonella Santuccione MD PhD

Strategy

WBP, Roche, Biogen

robert

Robert Hett, PhD

CMC & Quality

Carbogen, RPD

andy

Andy Page

Commercialization

CEO Otsuka EU &
COO Beckley Psytech

manfred

Manfred Schneider, PhD

Toxicology & Preclinical

MerckSereno, Addex, AUC

fiona

Fiona Cilli, Pharm D

Clinical Operations

Sanofi, Zoersel

nick

Nicholas Draeger, PhD

BD & Strategy

Roche, NHS, Innosuisse

ruth

Ruth Stevens, PhD

Regulatory Consultant

Founder, Camargo
Premier Consulting

claire

Claire Gillis, PhD

Market Access Advisor

CEO, VLMYR Health. WPP

micahel_k

Michael Kometer, PhD

Board Chairman & Co-founder

Neuronomics

gloria_pic

Victoria Hale, PhD

Board of Directors

FDA, Medicines 360,
MAPS Board Chair

david_langer

David Langer

Board Member

Founding Partner,
Lionheart Ventures

Scientific Advisors
eus

Eus van Sommeren, PhD

Stress-induced Insomnia

Head of the Department Sleep & Cognition
University of Amsterdam

hape

Hans-Peter Landolt, PhD

Sleep Pharmacology & Toxicology

University of Zurich

marcus

Marcus Herdener, MD PhD

Cocaine use disorder & addictions

Head of Center for Addictive Disorders
Psychiatric University Clinic, Zurich

erich

Erich Seifritz, MD PhD

Psychiatry & GAD

Director, Psychiatric University Clinic, Zurich

micahel_ashton

Michael Ashton

Pharmacokinetics & Drug Metabolism

Department of Pharmacology,
Institute of Neuroscience and Physiology,
University of Gothenburg

peter

Peter Gasser, MD

Clinical Advisor

Psychedelic Therapy
President, SAPT

We’d like to
hear from you.

info@reconnect-labs.com

    About Us

    Investors

    Our Work

    ©2024 Reconnect Labs AG. All rights reserved.

    Contact-Block

    We’d like to hear from you.

    info@reconnect-labs.com

      About Us

      Investors

      Our Work

      ©2024 Reconnect Labs AG. All rights reserved.

      Contact-Block